FR302M - Nouvelle m-butoxy-phénoxy-éthylamine utilisable en thérapeutique. - Google Patents

Nouvelle m-butoxy-phénoxy-éthylamine utilisable en thérapeutique.

Info

Publication number
FR302M
FR302M FR835450A FR835450A FR302M FR 302 M FR302 M FR 302M FR 835450 A FR835450 A FR 835450A FR 835450 A FR835450 A FR 835450A FR 302 M FR302 M FR 302M
Authority
FR
France
Prior art keywords
ethylamine
butoxy
phenoxy
usable
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR835450A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR809040A external-priority patent/FR1278618A/fr
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Priority to FR835450A priority Critical patent/FR302M/fr
Application granted granted Critical
Publication of FR302M publication Critical patent/FR302M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR835450A 1958-11-06 1960-08-10 Nouvelle m-butoxy-phénoxy-éthylamine utilisable en thérapeutique. Active FR302M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR835450A FR302M (fr) 1958-11-06 1960-08-10 Nouvelle m-butoxy-phénoxy-éthylamine utilisable en thérapeutique.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH6587558A CH380746A (de) 1958-11-06 1958-11-06 Verfahren zur Herstellung neuer sekundärer Amine
FR809040A FR1278618A (fr) 1958-11-06 1959-11-02 Procédé de préparation de nouvelles phénoxy-alcoyl-amines
FR835450A FR302M (fr) 1958-11-06 1960-08-10 Nouvelle m-butoxy-phénoxy-éthylamine utilisable en thérapeutique.

Publications (1)

Publication Number Publication Date
FR302M true FR302M (fr) 1961-03-20

Family

ID=4526704

Family Applications (1)

Application Number Title Priority Date Filing Date
FR835450A Active FR302M (fr) 1958-11-06 1960-08-10 Nouvelle m-butoxy-phénoxy-éthylamine utilisable en thérapeutique.

Country Status (3)

Country Link
US (1) US3105854A (fr)
CH (1) CH380746A (fr)
FR (1) FR302M (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6310252B1 (en) 1995-10-27 2001-10-30 Astrazeneca Ab [(3-alkoxy-phenoxy)-ethyl]-dialkylamine derivatives and their use as local anaesthetics

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1220440B (de) * 1962-02-14 1966-07-07 Sanol Arznei Schwarz Gmbh Verfahren zur Herstellung von Derivaten des 1-(o-Bromphenoxy)-2-hydroxy-3-amino-propans und deren Saeureadditionssalzen
US3205136A (en) * 1962-12-24 1965-09-07 Smith Kline French Lab Antidepressant phenyloxyalkylamines
US3988475A (en) * 1974-02-05 1976-10-26 Istituto Luso Farmaco D'italia S.R.L. Phenoxyalkylamines
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US6432986B2 (en) 1997-07-21 2002-08-13 Bruce H. Levin Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
SE9704770D0 (sv) * 1997-12-19 1997-12-19 Astra Ab New use
SE9704835D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New compound
MY155320A (en) 2007-10-05 2015-09-30 Acucela Inc Alkoxy compounds for disease treatment
EP2448569B1 (fr) 2009-07-02 2021-10-27 Acucela, Inc. Pharmacologie de modulateurs du cycle visuel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB300695A (en) * 1927-08-18 1928-11-19 Ig Farbenindustrie Ag Process for the manufacture of basic ethers of resorcinol
US2765338A (en) * 1952-06-08 1956-10-02 Cilag Ltd New aliphatic acid amide derivatives and processes for the production thereof
US2967201A (en) * 1958-06-02 1961-01-03 Lilly Co Eli Alkylaminoalkyl ethers of phenols

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6310252B1 (en) 1995-10-27 2001-10-30 Astrazeneca Ab [(3-alkoxy-phenoxy)-ethyl]-dialkylamine derivatives and their use as local anaesthetics

Also Published As

Publication number Publication date
US3105854A (en) 1963-10-01
CH380746A (de) 1964-08-15

Similar Documents

Publication Publication Date Title
FR302M (fr) Nouvelle m-butoxy-phénoxy-éthylamine utilisable en thérapeutique.
FR308M (fr) Nouvelle pyridyl-éthyl-guanidine utilisable en thérapeutique.
FR164M (fr) Nouvelle hydrazine utilisable en thérapeutique.
FR1898M (fr) Nouvelle substance utilisable en thérapeutique.
FR221M (fr) Nouvelle guanidine utilisable en thérapeutique.
FR349M (fr) Nouvelle 1,3-dihydroxy-2-nitro-tricos-4-yne utilisable en thérapeutique.
FR163M (fr) Nouvelle phénoxy-éthylamine utilisable en thérapeutique.
FR353M (fr) Nouvelle quinoléine utilisable en thérapeutique.
FR310M (fr) Nouvelle aza-hexylene-imino-éthyl-guanidine utilisable en thérapeutique.
BE581628A (fr) Etireur-tordeur.
BE596272A (fr) Nouvelle substance utilisable en thérapeutique.
FR115M (fr) Nouveau sulfonamide utilisable en thérapeutique.
FR350M (fr) Nouvel antibiotique lankavamycine utilisable en thérapeutique.
FR303M (fr) Nouvelle guanidine utilisable en thérapeutique.
FR116M (fr) Nouveau dérivé sulfonamidique utilisable en thérapeutique.
FR222M (fr) Nouvelle 2,5-bis-éthylene-imino-3,6-bis-acylamino-p-benzoquinone utilisable en thérapeutique.
DK106453C (da) Endoradiosonde.
BE583856A (fr) Agent opacifiant utilisable en readiologie.
FR1494M (fr) Nouvelle création en thérapeutique.
FR351M (fr) Nouvel antibiotique lankavacidine utilisable en thérapeutique.
FR352M (fr) Nouvel antibiotique ferrimycine utilisable en thérapeutique.
FI29893A (fi) Svällbara, syrafasta vattenglaskitt
GR19329B (el) Πολλαπλασιαστης ισχυος.
FR176M (fr) Nouvelles carbamylazétidines.
BE584923A (fr) Agent opacifiant utilisable en radiologie.